Cargando…
Multiple Reaction Monitoring-Mass Spectrometry Enables Robust Quantitation of Plasma Proteins Regardless of Whole Blood Processing Delays That May Occur in the Clinic
Plasma is an important biofluid for clinical research and diagnostics. In the clinic, unpredictable delays—from minutes to hours—between blood collection and plasma generation are often unavoidable. These delays can potentially lead to protein degradation and modification and might considerably affe...
Autores principales: | Gaither, Claudia, Popp, Robert, Zahedi, René P., Borchers, Christoph H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9062485/ https://www.ncbi.nlm.nih.gov/pubmed/35182769 http://dx.doi.org/10.1016/j.mcpro.2022.100212 |
Ejemplares similares
-
Sex or no sex: Evolutionary adaptation occurs regardless
por: Seidl, Michael F, et al.
Publicado: (2014) -
Utility, promise, and limitations of liquid chromatography‐mass spectrometry‐based therapeutic drug monitoring in precision medicine
por: Gaspar, Vanessa P., et al.
Publicado: (2021) -
Early Prediction of COVID-19 Patient Survival by Targeted Plasma Multi-Omics and Machine Learning
por: Richard, Vincent R., et al.
Publicado: (2022) -
Amino acid analysis for peptide quantitation using reversed-phase liquid chromatography combined with multiple reaction monitoring mass spectrometry
por: Qasrawi, Deema O., et al.
Publicado: (2023) -
Systematic Optimization of the iMALDI Workflow for the Robust and Straightforward Quantification of Signaling Proteins in Cancer Cells
por: Froehlich, Bjoern C., et al.
Publicado: (2020)